Johnson & JohnsonvsPro-Dex

JNJ and PDEX stock compared: price, dividend, valuation and results, from SEC filings.

PDEX

Pro-Dex, Inc.

$61.93

Value $198M

-3.95%
PDEX's page

Johnson & Johnson (JNJ) has a market value of $672B and Pro-Dex (PDEX) $198M. Over the last year, with dividends, JNJ moved +45.4% and PDEX +93.0%. The P/E is 41.7 for JNJ and 16.5 for PDEX. Dividend yield: JNJ 1.89%, PDEX none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    JNJ$672B

    PDEX$198M

    JNJ is 3,386 times PDEX

  • Revenue, 12 months

    JNJ$99.3B

    PDEX$80M

    JNJ is 1,248 times PDEX

  • Net income, 12 months

    JNJ$16.1B

    PDEX$12M

    JNJ is 1,338 times PDEX

  • Operating margin

    JNJ–

    PDEX16.8%

  • ROIC

    JNJ12.4%

    PDEX17.4%

    5.0 points apart

  • P/E

    JNJ41.7

    PDEX16.5

    JNJ is 2.5 times PDEX

  • Dividend yield

    JNJ1.9%

    PDEX0.0%

    1.9 points apart

  • 5-year return

    JNJ+97.0%

    PDEX+193.4%

    96.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

JNJ+97.0%

PDEX+193.4%

10020030020222023202420252026
Returns by period
PeriodJNJWith dividendsPDEXWith dividends
1 year since November 14, 2025+45.4%Price +42.2%+93.0%Price +93.0%
3 years since November 17, 2023+102.6%+26.5% a yearPrice +86.1%+262.2%+53.6% a yearPrice +262.2%
5 years since November 16, 2021+97.0%+14.5% a yearPrice +71.3%+193.4%+24.0% a yearPrice +193.4%
10 years since November 17, 2016+213.7%+12.1% a yearPrice +139.1%+1,217.7%+29.4% a yearPrice +1,217.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

JNJJohnson & JohnsonPDEXPro-Dex

Valuation

JNJPDEX
Valuation
Price$278.70$61.93
Market value$672B$198M
Enterprise value (EV)$699B$202M
P/E41.716.5
P/E, 5-year median21.914.2
P/B8.24.0
EV/EBIT39.415.1
Free cash flow yield3.1%5.4%

Results and growth

JNJPDEX
Results and growth
Revenue, 12 months$99.3B$80M
Net income, 12 months$16.1B$12M
Free cash flow, 12 months$20.6B$11M
Earnings per share, 12 months$6.59$3.63
Revenue growth, year on year6.1%16.5%
Revenue growth a year, past+2.7%over 5 years+15.3%over 5 years
EPS growth a year, past+14.9%over 5 years+21.3%over 5 years

Margins and returns on capital

JNJPDEX
Margins and returns on capital
Gross margin67.6%32.5%
Operating margin–16.8%
Net margin16.2%15.1%
ROIC12.4%17.4%
ROE19.7%26.7%

Balance sheet

JNJPDEX
Balance sheet
Cash$17.2B$13M
Total debt$44.7B$19M
Net debt / EBITDA1.10.2
Interest cover18.0×15.4×

Dividends and buybacks

JNJPDEX
Dividends and buybacks
Dividend yield1.9%–
Dividend per share, 12 months$5.28–
Dividend growth a year, past+5.3%over 5 years–
Buyback yield0.9%1.7%
Shareholder yield2.8%1.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: JNJ or PDEX

Didn't find what you were looking for?

Ask us
Which is bigger, Johnson & Johnson or Pro-Dex?

By market value, Johnson & Johnson ($672B) is about 3,385.6 times Pro-Dex ($198M), at today's prices.

How did JNJ and PDEX stock do over the last 10 years?

Since November 17, 2016, JNJ's price moved +139.1% and PDEX's +1,217.7%. With dividends: JNJ +213.7% (+12.1% a year), PDEX +1,217.7% (+29.4% a year). Past returns do not predict future ones.

Which pays the higher dividend, JNJ or PDEX?

The dividend yield at today's price is 1.89% for Johnson & Johnson and none for Pro-Dex. Over the last twelve months they paid $5.28 and – per share.

What is the P/E of JNJ and PDEX?

At today's price, the P/E is 41.7 for JNJ and 16.5 for PDEX. The median of the last five years was 21.9 and 14.2, which shows where each stands against its own past.

Which has the higher profit margins, Johnson & Johnson or Pro-Dex?

Over the last twelve months, the net margin was 16.2% for Johnson & Johnson and 15.1% for Pro-Dex, and the operating margin – and 16.8%. Revenue was $99.3B and $80M.

Which is the better investment, Johnson & Johnson or Pro-Dex?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.